These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3918627)

  • 1. Prescribing: the power to set limits.
    Harding JM; Modell M; Freudenberg S; MacGregor R; Rea JN; Steen CA; Wojciechowski M; Yudkin GD
    Br Med J (Clin Res Ed); 1985 Feb; 290(6466):450-3. PubMed ID: 3918627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing a drug formulary to general practice--effects on practice prescribing costs.
    Beardon PH; Brown SV; Mowat DA; Grant JA; McDevitt DG
    J R Coll Gen Pract; 1987 Jul; 37(300):305-7. PubMed ID: 3449632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing costs and patterns of prescribing in general practice.
    Taylor RJ
    J R Coll Gen Pract; 1978 Sep; 28(194):531-5. PubMed ID: 739455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a core drug list towards improving prescribing education and reducing errors in the UK.
    Baker E; Roberts AP; Wilde K; Walton H; Suri S; Rull G; Webb A
    Br J Clin Pharmacol; 2011 Feb; 71(2):190-8. PubMed ID: 21219399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate prescribing in asthma and its related cost in east London.
    Naish J; Sturdy P; Toon P
    BMJ; 1995 Jan; 310(6972):97-100. PubMed ID: 7833736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing costs when computers are used to issue all prescriptions.
    Donald JB
    BMJ; 1989 Jul; 299(6690):28-30. PubMed ID: 2503199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing to generic formulary: how one fundholding practice reduced prescribing costs.
    Dowell JS; Snadden D; Dunbar JA
    BMJ; 1995 Feb; 310(6978):505-8. PubMed ID: 7677830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of regression analysis to explain the variation in prescribing rates and costs between family practitioner committees.
    Forster DP; Frost CE
    Br J Gen Pract; 1991 Feb; 41(343):67-71. PubMed ID: 2031739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data.
    Ross SM; Papshev D; Murphy EL; Sternberg DJ; Taylor J; Barg R
    J Manag Care Pharm; 2005 Jun; 11(5):410-5. PubMed ID: 15934800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug formularies--good or evil? A view using prescribing analyses and cost trends data.
    Chapman S
    Cardiology; 1994; 85 Suppl 1():46-53. PubMed ID: 7743535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?
    Huskamp HA; Epstein AM; Blumenthal D
    Health Aff (Millwood); 2003; 22(3):149-58. PubMed ID: 12757279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing analysis and cost tabulation (PACT) data: an introduction.
    Lovejoy AE; Savage I
    Br J Community Nurs; 2001 Feb; 6(2):62-7. PubMed ID: 11927873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in drug prescribing under the Public Health Reform Law--a survey of general practitioners' attitudes in East and West Germany.
    Himmel W; Kron M; Thies-Zajonc S; Kochen MM
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):164-9. PubMed ID: 9112138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can rational prescribing be assessed?
    van Zwanenberg TD; Grant GB; Gregory DA
    J R Coll Gen Pract; 1987 Jul; 37(300):308-10. PubMed ID: 3449633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal formularies. An index of prescribing quality?
    Robertson J; Fryer JL; O'Connell DL; Smith AJ; Henry DA
    Eur J Clin Pharmacol; 2001 Jul; 57(4):333-41. PubMed ID: 11549213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states.
    Khan S; Sylvester R; Scott D; Pitts B
    J Manag Care Pharm; 2008 Oct; 14(8):780-9. PubMed ID: 18983207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing indicators and their use by primary care groups to influence prescribing.
    Ashworth M; Golding S; Majeed A
    J Clin Pharm Ther; 2002 Jun; 27(3):197-204. PubMed ID: 12081633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of a general practice group intervention on prescribing costs and patterns.
    Walker J; Mathers N
    Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.